5//SEC Filing
DOCKERY CARL 5
Accession 0000912282-25-001096
CIK 0001385818other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 3:56 PM ET
Size
8.4 KB
Accession
0000912282-25-001096
Insider Transaction Report
Form 5
DOCKERY CARL
Director
Transactions
- Purchase
Common Shares
2020-11-18$0.92/sh+10,000$9,230→ 50 total(indirect: By LLC) - Sale
Common Shares
2020-12-30$6.01/sh−209$1,256→ 0 total(indirect: Alpha Venture Capital Parner, LP)
Holdings
- 21,152
Common Shares
Footnotes (3)
- [F1]The Reporting Person's purchase and sale of AYTU common shares (the "Shares") reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 209 Shares sold on December 30, 2020, with the Reporting Person's purchase of 10,000 Shares on November 18, 2020. After taking into consideration the Issuer's 10:1 reverse stock split on December 10, 2020, the price for the November 18, 2020, purchase was $9.23 per share, or a total purchase price of $1,929.07 for 209 Shares. The total sale price of 209 Shares on December 30, 2020, was $1,256.09. THE REPORTING PERSON DID NOT REALIZE ANY PROFIT IN CONNECTION WITH THE SHORT-SWING PURCHASE AND SALE.
- [F2]Represents total Shares held following stock splits on June 30, 2016 (12:1), August 25, 2017 (20:1), August 13, 2018 (20:1), December 10, 2020 (10:1) and January 6, 2023 (20:1).
- [F3]Includes 10,000 restricted shares granted to the Reporting Person on October 3, 2025, and reported on a Form 4 filed with the Securities and Exchange Commission on October 7, 2025.
Documents
Issuer
AYTU BIOPHARMA, INC
CIK 0001385818
Entity typeother
Related Parties
1- filerCIK 0001618149
Filing Metadata
- Form type
- 5
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 3:56 PM ET
- Size
- 8.4 KB